Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2020
Americas
Europe
Clear all
Type of publications
NITAG documentation
(82)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(65)
Europe
(21)
Africa
(2)
South-East Asia
(1)
Western Pacific
(20)
Countries
Belgium
(1)
Canada
(4)
Chile
(9)
Denmark
(1)
France
(5)
Netherlands
(1)
Sweden
(1)
United Kingdom
(11)
United States of America
(52)
Diseases
COVID-19
(79)
Human papillomavirus (HPV)
(8)
Diphtheria
(1)
Ebola
(3)
Hepatitis A
(1)
Influenza
(9)
Measles
(1)
Meningococcal disease
(1)
Pertussis
(1)
Pneumococcal disease
(3)
Tetanus
(1)
Tuberculosis
(1)
Typhoid
(1)
Varicella
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Efficacy/effectiveness
(1)
Target population
Adolescents
(3)
Adults
(3)
Healthcare workers
(5)
Older adults
(2)
Parents/caregivers
(2)
Risk group
(3)
Publication date
2020
(86)
2024
(2)
2023
(27)
2022
(85)
2021
(145)
2019
(18)
2018
(18)
2017
(14)
2016
(18)
2015
(12)
2014
(17)
2013
(6)
2012
(2)
2011
(3)
2010
(7)
2009
(5)
2008
(2)
2007
(4)
86 results found
2020
∙
Vu, M. Berg, C. J. Escoffery, C. Jang, H. M. Nguyen, T. T. Travis, L. Bednarczyk, R. A.
A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans’ human papillomavirus vaccine intention and uptake
2020
∙
Avni-Singer, L. R. Yakely, A. Sheth, S. S. Shapiro, E. D. Niccolai, L. M. Oliveira, C. R.
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
2020
∙
Rodriguez, S. A. Mullen, P. D. Lopez, D. M. Savas, L. S. Fernandez, M. E.
Factors associated with adolescent HPV vaccination in the U.S.: A systematic review of reviews and multilevel framework to inform intervention development
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
CAVEI
CAVEI recommendation to prioritize vaccination against SARS-COV-2 in people over 65 years in the context of limited supply of vaccines
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Sars-Cov-2 vaccination strategy - Preliminary recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
Melinda Wharton, ACIP
ACIP COVID-19 Vaccine Safety Technical Sub-Group
2020
∙
Beth Bell, ACIP
ACIP COVID-19 Vaccines Work Group - overview of American vaccines in development
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
Thomas Clark, ACIP
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register